[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100594299":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":28,"locations":34,"responsibleParty":135,"collaborators":137,"id":141,"slug":142,"hasResults":143,"nctId":144,"briefTitle":145,"officialTitle":146,"acronym":11,"eligibilityCriteria":147,"healthyVolunteers":143,"sex":148,"minAge":149,"maxAge":150,"enrollmentInfo":151,"targetDuration":11,"studyType":154,"phases":155,"briefSummary":157,"conditions":158,"keywords":11,"overallStatus":37,"whyStopped":11,"lastUpdateSubmitDate":160,"lastUpdatePostDateStruct":161,"startDateStruct":164,"completionDateStruct":166,"leadSponsor":168,"locationsCount":169},{"fullName":5,"class":6},"CGBio Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Novosis Putty","EXPERIMENTAL",null,[13],"Device: Novosis Putty",{"label":15,"type":16,"description":11,"interventionNames":17},"Standard of Care","ACTIVE_COMPARATOR",[18],"Other: Standard of Care",[20,24],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":11},"DEVICE","Single Level TLIF surgery with Novosis Putty",[9],{"type":25,"name":15,"description":26,"armGroupLabels":27,"otherNames":11},"OTHER","Single Level TLIF surgery with standard of care bone graft",[15],[29],{"name":30,"role":31,"phone":32,"phoneExt":11,"email":33},"Jumi Han","CONTACT","1.949.445.5965","Jumi.Han@CGBioUSA.com",[35,60,78,97,116],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"The Spine Center of Louisiana","RECRUITING","Baton Rouge","Louisiana","70809","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-91.18747,30.44332,{"lat":47,"lon":46},[50,55,57],{"name":51,"role":31,"phone":52,"phoneExt":53,"email":54},"Ana Heully","225-515-5700","1047","aheully@saon.net",{"name":56,"role":31,"phone":11,"phoneExt":11,"email":11},"Heather Bowman",{"name":58,"role":59,"phone":11,"phoneExt":11,"email":11},"Kevin McCarthy","PRINCIPAL_INVESTIGATOR",{"facility":61,"status":37,"city":62,"state":39,"zip":63,"country":41,"countryCode":42,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"LSU Health","Shreveport","71101",{"type":44,"coordinates":65},[66,67],-93.75018,32.52515,{"lat":67,"lon":66},[70,74,76],{"name":71,"role":31,"phone":72,"phoneExt":11,"email":73},"Saraith Bernard","281-236-8492","saraith.bernard@lsuhs.edu",{"name":75,"role":31,"phone":11,"phoneExt":11,"email":11},"Jessica Paul",{"name":77,"role":59,"phone":11,"phoneExt":11,"email":11},"Anthony Sin",{"facility":79,"status":37,"city":80,"state":81,"zip":82,"country":41,"countryCode":42,"cosmosGeoPoint":83,"geoPoint":87,"contacts":88},"Thomas Jefferson University - Department of Neurological Surgery","Philadelphia","Pennsylvania","19107",{"type":44,"coordinates":84},[85,86],-75.16362,39.95238,{"lat":86,"lon":85},[89,93,95],{"name":90,"role":31,"phone":91,"phoneExt":11,"email":92},"Mary Gomez","215-503-4852","mary.gomez@jefferson.edu",{"name":94,"role":31,"phone":11,"phoneExt":11,"email":11},"Sha'Mere Herder",{"name":96,"role":59,"phone":11,"phoneExt":11,"email":11},"Joshua Heller",{"facility":98,"status":37,"city":99,"state":100,"zip":101,"country":41,"countryCode":42,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"American Neurospine Institute, PLLC","Frisco","Texas","75034",{"type":44,"coordinates":103},[104,105],-96.82361,33.15067,{"lat":105,"lon":104},[108,112,114],{"name":109,"role":31,"phone":110,"phoneExt":11,"email":111},"Gladcy Mathew","469-989-3768","Gladcy.Mathew@hcahealthcare.com",{"name":113,"role":31,"phone":11,"phoneExt":11,"email":11},"Ezioma Akwara",{"name":115,"role":59,"phone":11,"phoneExt":11,"email":11},"Ripul Panchal",{"facility":117,"status":37,"city":118,"state":119,"zip":120,"country":41,"countryCode":42,"cosmosGeoPoint":121,"geoPoint":125,"contacts":126},"West Virginia University - Department of Orthopaedics","Morgantown","West Virginia","26506",{"type":44,"coordinates":122},[123,124],-79.9559,39.62953,{"lat":124,"lon":123},[127,131,133],{"name":128,"role":31,"phone":129,"phoneExt":11,"email":130},"Jennifer Eicher","304-293-2485","jeicher@hsc.wvu.edu",{"name":132,"role":31,"phone":11,"phoneExt":11,"email":11},"Monica Maxwell",{"name":134,"role":59,"phone":11,"phoneExt":11,"email":11},"Scott Daffner",{"type":136,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[138],{"name":139,"class":140},"CGBio USA","UNKNOWN","100594299","phase-3-efficacy-and-safety-of-novosis-putty-in-transforaminal-lumbar-interbody-fusion-for-patients-with-lumbar-degenerative-disc-disease-100594299",false,"NCT07017634","Efficacy and Safety of Novosis Putty in Transforaminal Lumbar Interbody Fusion for Patients With Lumbar Degenerative Disc Disease","Efficacy and Safety of Novosis Putty in Transforaminal Lumbar Interbody Fusion for Patients With Lumbar Degenerative Disc Disease : A Pivotal, Randomized, Prospective, Multi-Center Study","Inclusion Criteria:\n\n* Has a primary diagnosis of symptomatic lumbar degeneration with or without foraminal or recess stenosis of the lumbar confirmed by subject history and radiographic imaging (CT, MRI, X-rays) with no more than a Grade 2 (≤50% translation) spondylolisthesis. Symptomatic lumbar degeneration (L1 to S1) that may be associated with a co-morbid condition.\n* Has a history of failure conservative treatment (e.g. bed rest, physical therapy, medications, transcutaneous electrical nerve stimulation (TENS), manipulation, and\u002For spinal injections) for at least 6 months\n* Has preoperative Oswestry Disability Index score ≥ 40\u002F100 at baseline\n* Male or Female, 21-80 years of age and skeletally mature at the time of surgery\n* Psychosocially, mentally and physically able to fully comply with this protocol including adhering to follow-up schedule and requirements and filling out forms\n* Signed informed consent\n\nExclusion Criteria:\n\n* Previous instrumented surgery (i.e.: anterior disc replacement, spinal fusion, interspinous device, etc.) at the index lumbar level or an adjacent level;\n* Degenerative or lytic spondylolisthesis greater than Grade 2 (50% translation);\n* Active malignancy: A patient with a history of any invasive malignancy (except non-melanoma skin cancer), unless he\u002Fshe has been treated with curative intent and there have been no clinical signs or symptoms of the malignancy for at least 5 years;\n* Any degenerative muscular or neurological condition that would interfere with evaluation of outcomes, including but not limited to Parkinson's disease, amyotrophic lateral sclerosis (ALS), or multiple sclerosis;\n* Has chronic or acute renal and\u002For hepatic impairment and\u002For failure or prior history of renal and\u002For hepatic parenchymal disease;\n* Lactating, pregnant or interested in becoming pregnant in the next 3 years;\n* Is currently participating in an investigational therapy (device and\u002For pharmaceutical) within 30 days prior to entering the study or such treatment is planned during the 24 months following enrollment into the study.\n* Known hypersensitivity or allergy to any components of the study treatments inclusive of hypersensitivity or allergy to any BMP-2 type recombinant proteins or peptides.","ALL","21 Years","80 Years",{"count":152,"type":153},316,"ESTIMATED","INTERVENTIONAL",[156],"PHASE3","Efficacy and Safety of Novosis Putty in Transforaminal Lumbar Interbody Fusion for Patients with Lumbar Degenerative Disc Disease : A Pivotal, Randomized, Prospective, Multi-Center Study",[159],"Degenerative Disc Disease","2026-05-06",{"date":162,"type":163},"2026-05-08","ACTUAL",{"date":165,"type":153},"2026-05",{"date":167,"type":153},"2031-11",{"name":5,"class":6},5]